ClinicalTrials.govpublic full text
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
acute myelogenous leukemia, diffuse large b-cell leukemia, chronic lymphocytic leukemia, follicular lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846458
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.